| Financial Year |
March 31 2023 |
| Monetary Funds |
3,234,219,188.88 |
| Held-for-trading Financial Assets |
802,742,569.12 |
| Notes Receivable |
-- |
| Accounts Receivable |
49,833,550.38 |
| Advances to Suppliers |
16,406,684.59 |
| Other Receivables |
3,162,362.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
676,064,585.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,094,777,770.86 |
| Total Current Assets |
6,877,206,711.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,129,255,962.60 |
| Under-construction Projects |
73,926,685.35 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
496,358,625.29 |
| R&D expenses |
-- |
| Goodwill |
38,913,076.54 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
23,292,497.85 |
| Other Non-Current Assets |
84,231,170.96 |
| Sub-Total of Non-Current Assets |
1,849,482,510.60 |
| Total Assets |
8,726,689,221.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
210,863,388.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
41,348,412.40 |
| Taxes Payable |
59,024,906.97 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
215,630,586.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
11,681,914.28 |
| Sub-Total of Current Liabilities |
600,024,901.51 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
11,833,343.46 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
19,033,607.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
110,181,249.84 |
| Total Liabilities |
710,206,151.35 |
| Paid-In Capital(Or Share Stock) |
887,630,022.00 |
| Capital Surplus |
3,202,939,846.43 |
| Surplus Reserve |
345,917,805.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,579,995,396.35 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,016,483,070.40 |
| Owner's Equity（Stockholder's Equity） |
8,016,483,070.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,726,689,221.75 |
